Global Preclinical CRO Treatment Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Preclinical CRO Treatment Market Research Report 2024
Preclinical contract research organizations (CROs) offer research and development services to pharmaceutical and biotechnology companies during the early stages of drug development, including preclinical studies and animal testing.
According to Mr Accuracy reports new survey, global Preclinical CRO Treatment market is projected to reach US$ 1612.8 million in 2029, increasing from US$ 714.3 million in 2022, with the CAGR of 12.2% during the period of 2024 to 2029.
The market for preclinical CRO services is driven by the demand for specialized expertise and resources in drug development and the need for efficient and cost-effective preclinical research. The market's growth is also influenced by the increasing outsourcing of preclinical studies by pharmaceutical and biotech companies.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Preclinical CRO Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Charles River Laboratories
Laboratory Corporation of America
Envigo
Eurofins Scientific
PRA Health Science
Wuxi Apptec Co.,Ltd.
Medpace
Pharmaceutical Product Development
Paraxel
Pharmaron
Joinn Laboratories
Medicilon Inc.
Crown Bioscience
Yinuosi Bio-Technology
Segment by Type
Bioanalysis and DMPK Studies
Toxicology Testing
Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Preclinical CRO Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Preclinical CRO Treatment market is projected to reach US$ 1612.8 million in 2029, increasing from US$ 714.3 million in 2022, with the CAGR of 12.2% during the period of 2024 to 2029.
The market for preclinical CRO services is driven by the demand for specialized expertise and resources in drug development and the need for efficient and cost-effective preclinical research. The market's growth is also influenced by the increasing outsourcing of preclinical studies by pharmaceutical and biotech companies.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Preclinical CRO Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Charles River Laboratories
Laboratory Corporation of America
Envigo
Eurofins Scientific
PRA Health Science
Wuxi Apptec Co.,Ltd.
Medpace
Pharmaceutical Product Development
Paraxel
Pharmaron
Joinn Laboratories
Medicilon Inc.
Crown Bioscience
Yinuosi Bio-Technology
Segment by Type
Bioanalysis and DMPK Studies
Toxicology Testing
Segment by Application
Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Preclinical CRO Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source